Papers - NIIOKA Takenori
-
Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease.
Togashi Masaru, Niioka Takenori, Komatsuda Atsushi, Nara Mizuho, Okuyama Shin, Omokawa Ayumi, Abumiya Maiko, Wakui Hideki, Takahashi Naoto, Miura Masatomo
Eur J Clin Pharmacol 71 ( 9 ) 1091 - 1097 2015.9
-
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer.
Kobayashi Hiroyuki, Sato Kazuhiro, Niioka Takenori, Miura Hajime, Ito Hiroshi, Miura Masatomo
Clin Lung Cancer 16 ( 4 ) 274 - 281 2015.7
-
Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation.
Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Int J Mol Sci 16 ( 1 ) 1840 - 1854 2015.1
-
Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis.
Niioka Takenori, Komatsuda Atsushi, Kato Shotaro, Togashi Masaru, Okuyama Shin, Omokawa Ayumi, Nara Mizuho, Wakui Hideki, Takahashi Naoto, Miura Masatomo
Xenobiotica 45 ( 12 ) 1147 - 1153 2015
-
Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.
Numakura Kazuyuki, Kagaya Hideaki, Yamamoto Ryohei, Komine Naoki, Saito Mitsuru, Hiroshi Tsuruta, Akihama Susumu, Inoue Takamitsu, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Niioka Takenori, Miura Masatomo, Satoh Shigeru
Dis Markers 2015 179434 - 179434 2015
-
Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation.
Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Numakura Kazuyuki, Inoue Takamitsu, Saito Mitsuru, Komine Naoki, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Miura Masatomo
Pharmacogenomics 15 ( 11 ) 1495 - 1506 2014.8
-
A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patients.
Shida Seiji, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Matsumoto Morio, Hagihara Masao, Kobayashi Takahiro, Abumiya Maiko, Kameoka Yoshihiro, Fujishima Naohito, Tagawa Hiroyuki, Hirokawa Makoto, Sawada Kenichi
Ther Drug Monit 36 ( 4 ) 505 - 509 2014.8
-
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.
Takahashi Naoto, Miura Masatomo, Kuroki Jun, Mitani Kinuko, Kitabayashi Atsushi, Sasaki Osamu, Kimura Hideo, Imai Kiyotoshi, Tsukamoto Norifumi, Noji Hideyoshi, Kondo Takeshi, Motegi Mutsuhito, Kato Yuichi, Mita Masayuki, Saito Hajime, Yoshida Chikashi, Torimoto Yoshihiro, Kimura Tomofumi, Wano Yuji, Nomura Jun, Yamamoto Satoshi, Mayama Ko, Honma Riko, Sugawara Tomohiro, Sato Shinji, Shinagawa Atsushi, Abumiya Maiko, Niioka Takenori, Harigae Hideo, Sawada Kenichi
Biomark Res 2 ( 1 ) 6 - 6 2014.3
-
A limited sampling strategy for estimation of the area under the plasma concentration-time curve of gefitinib.
Miura Masatomo, Sato Kazuhiro, Miura Hajime, Niioka Takenori, Kobayashi Hiroyuki, Narita Chihiro, Ito Hiroshi
Ther Drug Monit 36 ( 1 ) 24 - 29 2014.2
-
Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
Hinai Y, Motoyama S, Niioka T, Miura M
J Clin Pharm Ther 38 ( 6 ) 498 - 503 2013.12
-
Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.
Niioka Takenori, Kagaya Hideaki, Miura Masatomo, Numakura Kazuyuki, Saito Mitsuru, Inoue Takamitsu, Habuchi Tomonori, Satoh Shigeru
Eur J Clin Pharmacol 69 ( 9 ) 1659 - 1665 2013.9
-
A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction.
Shinohara Yoshinori, Takahashi Naoto, Nishiwaki Kaichi, Hino Masayuki, Kashimura Makoto, Wakita Hisashi, Hatano Yoshiaki, Hirasawa Akira, Nakagawa Yasuaki, Itoh Kuniaki, Masuoka Hidekazu, Aotsuka Nobuyuki, Matsuura Yasuhiro, Takahara Sinobu, Sano Koji, Kuroki Jun, Hata Tomoko, Nakamae Hirohisa, Mugitani Atsuko, Nakane Takahiko, Miyazaki Yasushi, Niioka Takenori, Miura Masatomo, Sawada Kenichi
Haematologica 98 ( 9 ) 1407 - 1413 2013.9
-
Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
Nara Miho, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Kagaya Hideaki, Fujishima Naohito, Saitoh Hirobumi, Kameoka Yoshihiro, Tagawa Hiroyuki, Hirokawa Makoto, Sawada Kenichi
Eur J Clin Pharmacol 69 ( 6 ) 1321 - 1329 2013.6
-
A limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients.
Niioka Takenori, Miura Masatomo, Kagaya Hideaki, Saito Mitsuru, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru
Ther Drug Monit 35 ( 2 ) 228 - 232 2013.4
-
Study on improvement of the accuracy and precision of predicted plasma concentration of vancomycin in the administration planning support for children
Itagaki Shirou, Hayakari Makoto, Kudo Masakiyo, Niioka Takenori, Uchiyama Michiko, Kanazawa Sachiko, Hosoi Kazuhiro, Terui Kazufumi, Kojima Keiya, Yasujima Minoru
Hirosaki Medical Journal 64 ( 1 ) 58 - 64 2013
-
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka Takenori, Satoh Shigeru, Kagaya Hideaki, Numakura Kazuyuki, Inoue Takamitsu, Saito Mitsuru, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Miura Masatomo
Transplantation 94 ( 10 ) 1013 - 1019 2012.11
-
H2-receptor antagonist influences dasatinib pharmacokinetics in a patient with Philadelphia-positive acute lymphoblastic leukemia.
Matsuoka Akihito, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Kawakami Kimihiro, Matsunaga Takuya, Sawada Kenichi
Cancer Chemother Pharmacol 70 ( 2 ) 351 - 352 2012.8
-
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation.
Takahashi Naoto, Miura Masatomo, Scott Stuart A, Niioka Takenori, Sawada Kenichi
J Hematol Oncol 5 23 - 23 2012.5
-
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Saruwatari Junji, Yasui-Furukori Norio, Niioka Takenori, Akamine Yumiko, Takashima Ayaka, Kaneko Sunao, Uno Tsukasa
J Clin Psychopharmacol 32 ( 2 ) 195 - 199 2012.4
-
Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi Naoto, Miura Masatomo, Niioka Takenori, Sawada Kenichi
Cancer Chemother Pharmacol 69 ( 4 ) 999 - 1004 2012.4